A side-by-side comparison of iShares Biotechnology ETF (IBB) and Harvest Healthcare Leaders Income ETF (HHL) to help Canadian investors make an informed decision.
1-Year Performance
Normalised to 100 at the start — shows relative return over the trailing 12 months.
Head-to-Head Comparison
| Metric | IBB | HHL |
|---|---|---|
| YTD Return | +25.62%✓ | -0.39% |
| 1-Day Change | +0.70% | +0.79%✓ |
| 1-Week Change | +3.97%✓ | +0.39% |
| 1-Month Change | +3.48%✓ | +4.48% |
| Current Price | $217.86 | $7.69 |
| AUM | $11.03B✓ | $1.96B |
| MER (Expense Ratio) | 0.46% | — |
| Dividend Yield | 0.16% | 9.59%✓ |
| Distribution Frequency | NA | — |
| Inception Date | 2001-02-05 | 2014-12-18 |
| Holdings Count | 236 | 10 |
| MorningStar Rating | — | — |
| Category | Healthcare Equity | Healthcare Equity |
| Beta | 0.70 | 0.97 |
| 52-Week High | $220.31 | $7.70 |
| 52-Week Low | $154.31 | $6.35 |
| 50-Day MA | $208.27 | $7.43 |
| 200-Day MA | $184.29 | $7.27 |
✓ marks the better value for return/yield/AUM metrics. Lower ✓ for MER.
Annualised Returns
| Period | IBB | HHL |
|---|---|---|
| YTD | +25.62%✓ | -0.39% |
| 1 Year | +36.32%✓ | +12.02% |
| 3 Year | +23.19%✓ | +11.38% |
| 5 Year | +6.57% | +7.35%✓ |
| 10 Year | +9.02%✓ | +8.93% |
| 1Y Volatility | 18.53% | 12.56% |
| Sharpe Ratio (3Y) | 0.80 | 0.37 |
Past performance is not a guarantee of future results.
Top 10 Holdings
| 1 | GILD | Gilead Sciences Inc | 8.18% |
| 2 | AMGN | Amgen Inc | 8.00% |
| 3 | VRTX | Vertex Pharmaceuticals Inc | 7.36% |
| 4 | REGN | Regeneron Pharmaceuticals Inc | 5.53% |
| 5 | MRNA | Moderna Inc | 5.07% |
| 6 | NTRA | Natera Inc | 3.88% |
| 7 | ARGX | argenx NV ADR | 3.48% |
| 8 | ILMN | Illumina Inc | 2.96% |
| 9 | BIIB | Biogen Inc | 2.54% |
| 10 | RVMD | Revolution Medicines Inc | 2.51% |
| 1 | A | Agilent Technologies Inc | 6.38% |
| 2 | TMO | Thermo Fisher Scientific Inc | 5.92% |
| 3 | ISRG | Intuitive Surgical Inc | 5.86% |
| 4 | DHR | Danaher Corporation | 5.74% |
| 5 | AMGN | Amgen Inc | 5.65% |
| 6 | VRTX | Vertex Pharmaceuticals Inc | 5.67% |
| 7 | REGN | Regeneron Pharmaceuticals Inc | 5.41% |
| 8 | MRK | Merck & Company Inc | 5.19% |
| 9 | JNJ | Johnson & Johnson | 4.95% |
| 10 | ABBV | AbbVie Inc | 4.91% |
Sector Weights
| Sector | IBB | HHL |
|---|---|---|
| Basic Materials | 0.00% | 0.00% |
| Communication Services | 0.00% | 0.00% |
| Consumer Cyclicals | 0.00% | 0.00% |
| Consumer Defensive | 0.00% | 0.00% |
| Energy | 0.00% | 0.00% |
| Financial Services | 0.00% | 0.00% |
| Healthcare | 100.00% | 100.00% |
| Industrials | 0.00% | 0.00% |
| Real Estate | 0.00% | 0.00% |
| Technology | 0.00% | 0.00% |
| Utilities | 0.00% | 0.00% |
About IBB
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
About HHL
US healthcare companies combine innovation with consistent demand. We all need healthcare, especially as the developed world ages and the developing world gets richer. Healthcare companies create value from new drugs, treatments, and technologies. HHL offers steady income and growth opportunities from large-cap US healthcare leaders.
Which ETF is Right for You?
Both IBB and HHL are listed on Canadian exchanges and accessible through most Canadian brokerages including Questrade, Wealthsimple Trade, TD Direct, and Interactive Brokers.
Based on the available data, IBB scores higher across our tracked metrics including YTD performance, dividend yield, and AUM — though both ETFs warrant individual research before investing.
- Consider your account type (TFSA, RRSP, non-registered) as it can affect dividend taxation.
- Compare management expense ratios (MER) directly on each provider's website.
- Look at average daily trading volume to assess liquidity.
- Review the fund's underlying index and holdings to ensure the exposure matches your goals.
This is not financial advice. Always do your own research or consult a licensed financial advisor before investing.
Frequently Asked Questions
What is the difference between IBB and HHL?
IBB (iShares Biotechnology ETF) and HHL (Harvest Healthcare Leaders Income ETF) are both Canadian-listed ETFs. Key differences include their AUM ($11.03B vs $1.96B), dividend yield (0.16% vs 9.59%), and year-to-date performance (+25.62% vs -0.39%).
Is IBB better than HHL?
There is no single "better" ETF — it depends on your investment goals. If you prioritise recent performance, IBB has outperformed year-to-date. Always review the fund's prospectus and consider your tax situation.
Can I buy IBB and HHL on Wealthsimple?
Most Canadian-listed ETFs are available on Wealthsimple Trade commission-free. Both IBB and HHL should be accessible. Check Wealthsimple's supported tickers list to confirm availability.
7 stocks to buy and hold forever
Complement your ETF portfolio with these proven long-term individual stocks.
Get the FREE Report